UBS Upgrades DaVita to Buy, Raises Price Target to $117

UBS analyst Andrew Mok upgrades DaVita (NYSE:DVA) from Neutral to Buy and raises the price target from $106 to $117.

UBS analyst Andrew Mok upgrades DaVita (NYSE:DVA) from Neutral to Buy and raises the price target from $106 to $117.

Total
0
Shares
Related Posts